Polyclonal Rabbit anti‑Human MAP2K2 / MKK2 / MEK2 Antibody (APC,Cy7, aa86‑331, WB) LS‑C735548
Polyclonal Rabbit anti‑Human MAP2K2 / MKK2 / MEK2 Antibody (APC,Cy7, aa86‑331, WB) LS‑C735548
Antibody:
MAP2K2 / MKK2 / MEK2 Rabbit anti-Human Polyclonal (aa86-331) (APC, Cy7) Antibody
Format:
Allophycocyanin, Cy7, Unmodified
Overview
Antibody:
MAP2K2 / MKK2 / MEK2 Rabbit anti-Human Polyclonal (aa86-331) (APC, Cy7) Antibody
Format:
Allophycocyanin, Cy7, Unmodified
Specifications
Description
MEK2 antibody LS-C735548 is an APC, Cy7-conjugated rabbit polyclonal antibody to human MEK2 (MAP2K2 / MKK2) (aa86-331). Validated for WB.
Target
Human MAP2K2 / MKK2 / MEK2
Synonyms
MAP2K2 | ERK activator kinase 2 | MAP kinase kinase 2 | MAPK/ERK kinase 2 | MAPKK 2 | MKK2 | MEK 2 | MEK2 | MAPKK2 | PRKMK2
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Allophycocyanin, Cy7.
Also available
Unconjugated or conjugated with
Biotin,
FITC,
Cy3,
HRP,
APC,
PE.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant MAP2K2 (Val86-Pro331)
Specificity
The antibody is a rabbit polyclonal antibody raised against MAP2K2.
Applications
- Western blot
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About MAP2K2 / MKK2 / MEK2
Featured Products
Source:
E. coli
Tag:
His-T7
Reactivity:
Rat
Range:
15.63-1000 pg/ml
Reactivity:
Rat
Range:
6.25-400 pg/ml
Source:
Human
Tag:
Myc-DDK (Flag)
Reactivity:
Monkey
Range:
0.313-20 ng/ml
Reactivity:
Range:
2.81-180 µmol/l
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 8/31/2024